Hypothesizing that the additional regression of tumors resistant to immunotherapy by serial ISIM is associated with restoring CD103+ DCs in the tumor, and facilitating oligoclonal infiltration of novel TCR repertoires, we examined the frequency of CD103+ DCs before and after ISIM. Here, ITGAE is linked to neoplasm.